ALX Oncology

$540.0K revenue • 3 employees • 323 Allerton Ave, South San Francisco, CA, 94080, United States

Last Updated Feb 19, 2026

Company Overview

Company Name

ALX Oncology

Address

323 Allerton Ave, South San Francisco, CA, 94080, United States

Approx. Annual Revenue

$0.5M

Employees

3

Established

2017

Google Reviews

5.0 (1 review)

About ALX Oncology

ALX Oncology is a clinical-stage biopharmaceutical company based in San Francisco, California, that is dedicated to developing novel approaches to optimize current and future standards of cancer care. The company's lead therapeutic candidate, evorpacept, has shown potential to become a cornerstone therapy in the evolving field of immuno-oncology.

Business Profile

Read from the ALX Oncology website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current announcements dated 2026; Complete navigation and contact info

Biotech & Life Sciences Companies near South San Francisco, CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about ALX Oncology

Categories

Technologies Used

Key Decision Makers

Janica Wong Director, Discovery Biology
LinkedIn
Emmanuel Ang Senior Clinical Trial Manager
LinkedIn
Shelly McCurry Senior Clinical Trial Manager
LinkedIn
Kim Nguyen Associate Clinical Trial Manager
LinkedIn